Jeffrey J Olson1, Steven N Kalkanis2, Timothy C Ryken3. 1. Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia. 2. Department of Neurosurgery, Henry Ford Health System, Detroit, Michigan. 3. Section of Neurosurgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Abstract
BACKGROUND: The Congress of Neurological Surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with metastatic brain tumors was first published in 2010. Because of the time elapsed since that publication, an update of this set of guidelines based on literature published since is now indicated. OBJECTIVE: To establish the best evidence-based management of metastatic brain tumors over all commonly used diagnostic and treatment modalities in regularly encountered clinical situations. METHODS: Literature searches regarding management of metastatic brain tumors with whole brain radiation therapy, surgery, stereotactic radiosurgery, chemotherapy, prophylactic anticonvulsants, steroids, instances of multiple brain metastases, and emerging and investigational therapies were carried out to answer questions designed by consensus of a multidisciplinary writing group. RESULTS: Recommendations were created and their strength linked to the quality of the literature data available thus creating an evidence-based guideline. Importantly, shortcomings and biases to the literature data are brought out so as to provide guidance for future investigation and improvements in the management of patients with metastatic brain tumors. CONCLUSION: This series of guidelines was constructed to assess the most current and clinically relevant evidence for management of metastatic brain tumors. They set a benchmark regarding the current evidence base for this management while also highlighting important key areas for future basic and clinical research, particularly on those topics for which no recommendations could be formulated.The full guideline can be found at: https://www.cns.org/guidelines-treatment-adults-metastatic-brain-tumors/chapter_1.
BACKGROUND: The Congress of Neurological Surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with metastatic brain tumors was first published in 2010. Because of the time elapsed since that publication, an update of this set of guidelines based on literature published since is now indicated. OBJECTIVE: To establish the best evidence-based management of metastatic brain tumors over all commonly used diagnostic and treatment modalities in regularly encountered clinical situations. METHODS: Literature searches regarding management of metastatic brain tumors with whole brain radiation therapy, surgery, stereotactic radiosurgery, chemotherapy, prophylactic anticonvulsants, steroids, instances of multiple brain metastases, and emerging and investigational therapies were carried out to answer questions designed by consensus of a multidisciplinary writing group. RESULTS: Recommendations were created and their strength linked to the quality of the literature data available thus creating an evidence-based guideline. Importantly, shortcomings and biases to the literature data are brought out so as to provide guidance for future investigation and improvements in the management of patients with metastatic brain tumors. CONCLUSION: This series of guidelines was constructed to assess the most current and clinically relevant evidence for management of metastatic brain tumors. They set a benchmark regarding the current evidence base for this management while also highlighting important key areas for future basic and clinical research, particularly on those topics for which no recommendations could be formulated.The full guideline can be found at: https://www.cns.org/guidelines-treatment-adults-metastatic-brain-tumors/chapter_1.
Authors: Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed Journal: J Neurooncol Date: 2021-02-21 Impact factor: 4.130
Authors: Susan M Chang; Hans Messersmith; Manmeet Ahluwalia; David Andrews; Priscilla K Brastianos; Laurie E Gaspar; Na Tosha N Gatson; Justin T Jordan; Mustafa Khasraw; Andrew B Lassman; Julia Maues; Maciej Mrugala; Jeffrey Raizer; David Schiff; Glen Stevens; Ashley Sumrall; Martin van den Bent; Michael A Vogelbaum Journal: J Clin Oncol Date: 2019-03-18 Impact factor: 44.544
Authors: Paul W Sperduto; Shane Mesko; Jing Li; Daniel Cagney; Ayal Aizer; Nancy U Lin; Eric Nesbit; Tim J Kruser; Jason Chan; Steve Braunstein; Jessica Lee; John P Kirkpatrick; Will Breen; Paul D Brown; Diana Shi; Helen A Shih; Hany Soliman; Arjun Sahgal; Ryan Shanley; William A Sperduto; Emil Lou; Ashlyn Everett; Drexell H Boggs; Laura Masucci; David Roberge; Jill Remick; Kristin Plichta; John M Buatti; Supriya Jain; Laurie E Gaspar; Cheng-Chia Wu; Tony J C Wang; John Bryant; Michael Chuong; Yi An; Veronica Chiang; Toshimichi Nakano; Hidefumi Aoyama; Minesh P Mehta Journal: J Clin Oncol Date: 2020-09-15 Impact factor: 44.544
Authors: Paul W Sperduto; Shane Mesko; Jing Li; Daniel Cagney; Ayal Aizer; Nancy U Lin; Eric Nesbit; Tim J Kruser; Jason Chan; Steve Braunstein; Jessica Lee; John P Kirkpatrick; Will Breen; Paul D Brown; Diana Shi; Helen A Shih; Hany Soliman; Arjun Sahgal; Ryan Shanley; William Sperduto; Emil Lou; Ashlyn Everett; Drexell Hunter Boggs; Laura Masucci; David Roberge; Jill Remick; Kristin Plichta; John M Buatti; Supriya Jain; Laurie E Gaspar; Cheng-Chia Wu; Tony J C Wang; John Bryant; Michael Chuong; James Yu; Veronica Chiang; Toshimichi Nakano; Hidefumi Aoyama; Minesh P Mehta Journal: Int J Radiat Oncol Biol Phys Date: 2020-02-19 Impact factor: 7.038
Authors: Paul W Sperduto; Brian De; Jing Li; David Carpenter; John Kirkpatrick; Michael Milligan; Helen A Shih; Tugce Kutuk; Rupesh Kotecha; Hajime Higaki; Manami Otsuka; Hidefumi Aoyama; Malie Bourgoin; David Roberge; Salah Dajani; Sean Sachdev; Jordan Gainey; John M Buatti; William Breen; Paul D Brown; Lisa Ni; Steve Braunstein; Matthew Gallitto; Tony J C Wang; Ryan Shanley; Emil Lou; Jay Shiao; Laurie E Gaspar; Satoshi Tanabe; Toshimichi Nakano; Yi An; Veronica Chiang; Liang Zeng; Hany Soliman; Hesham Elhalawani; Daniel Cagney; Evan Thomas; Drexell H Boggs; Manmeet S Ahluwalia; Minesh P Mehta Journal: Int J Radiat Oncol Biol Phys Date: 2022-03-21 Impact factor: 8.013
Authors: Nadine Heßler; Stephanie T Jünger; Anna-Katharina Meissner; Martin Kocher; Roland Goldbrunner; Stefan Grau Journal: BMC Cancer Date: 2022-03-15 Impact factor: 4.430
Authors: Petra Schödel; Stephanie T Jünger; Maike Wittersheim; Hans Christian Reinhardt; Nils-Ole Schmidt; Roland Goldbrunner; Martin Proescholdt; Stefan Grau Journal: Cancer Med Date: 2020-08-28 Impact factor: 4.452